A 28-year-old woman with bipolar I disorder has been on olanzapine 15 mg nightly for 18 months for mood stabilization. She now presents with amenorrhea for 4 months, galactorrhea, and gynecomastia. Serum prolactin is 85 ng/mL (normal <25 ng/mL). FSH and LH are low-normal. TSH is normal. She is not pregnant. What is the most likely mechanism of olanzapine-induced hyperprolactinemia in this patient?

Explanation

## Mechanism of Antipsychotic-Induced Hyperprolactinemia **Key Point:** All antipsychotics cause hyperprolactinemia through **dopamine D~2~ receptor blockade in the tuberoinfundibular pathway**. Dopamine is the primary inhibitor of prolactin release; blocking it removes tonic suppression, allowing prolactin to rise. ## Neuroendocrine Pathway ```mermaid flowchart TD A[Hypothalamus]:::outcome --> B[Dopamine released into hypophyseal portal blood]:::action B --> C[Dopamine binds D~2~ receptors on lactotroph cells]:::action C --> D[Tonic inhibition of prolactin secretion]:::action E[Antipsychotic blocks D~2~]:::urgent --> F[Loss of dopaminergic inhibition]:::urgent F --> G[Unopposed prolactin release]:::urgent G --> H[Hyperprolactinemia]:::outcome ``` ## Clinical Features of Antipsychotic-Induced Hyperprolactinemia | Feature | Mechanism | Prevalence | |---------|-----------|------------| | **Amenorrhea / Oligomenorrhea** | Prolactin suppresses GnRH → ↓ FSH/LH | 20–50% in women | | **Galactorrhea** | Direct lactotroph stimulation | 5–15% | | **Gynecomastia / Breast tenderness** | Prolactin-mediated estrogen effects | 10–20% in men | | **Sexual dysfunction** | Prolactin ↓ dopamine in mesolimbic reward pathway | 30–40% | | **Osteoporosis risk** | Chronic hypogonadism from prolactin excess | Long-term | ## Antipsychotic Propensity for Hyperprolactinemia **Mnemonic: ROPE** (Risperidone, Olanzapine, Paliperidone, Eosinophilia) — highest risk agents: - **Risperidone** — highest (prolactin often >100 ng/mL) - **Paliperidone** — very high (active metabolite of risperidone) - **Olanzapine** — moderate-to-high (as in this case) - **Quetiapine** — low - **Aripiprazole** — lowest (partial D~2~ agonist; may even lower prolactin) - **Lurasidone** — low **High-Yield:** Aripiprazole is the **only SGA that can lower prolactin** because it is a partial D~2~ agonist — it maintains some dopaminergic tone even while blocking excessive dopamine signaling. ## Why This Patient's Presentation Is Consistent Olanzapine 15 mg is a substantial dose with moderate-to-high prolactin elevation risk. The 4-month amenorrhea, galactorrhea, and markedly elevated prolactin (85 ng/mL) are classic features. Low-normal FSH/LH reflect prolactin-mediated suppression of GnRH. Normal TSH excludes primary hypothyroidism as a confound. **Clinical Pearl:** Hyperprolactinemia from antipsychotics is **dose-dependent and reversible** — switching to aripiprazole or reducing the dose can normalize prolactin within weeks to months. **Warning:** Do NOT attribute amenorrhea in a woman on antipsychotics to pregnancy, PCOS, or other causes without checking prolactin first. Antipsychotic-induced hyperprolactinemia is the most common drug-induced endocrine disorder in psychiatry. [cite:Stahl Psychopharmacology 6e Ch 5; Harrison 21e Ch 397]